Bonds & fixed income
PJPInvesco
Invesco Dynamic Pharmaceuticals ETF
$126.36+0.45% vs prior close
9513252-WK
Price through Oct 27, 2026 · Flows through Oct 26, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Oct 27, 2026. Holdings snapshot retrieved Oct 27, 2026.
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
PJP price
Source: Market tape, daily closes; price return, distributions not reinvested
Table
| Date | PJP close |
|---|---|
| Jul 27, 2026 | $120.60 |
| Jul 28, 2026 | $122.74 |
| Jul 29, 2026 | $122.33 |
| Jul 30, 2026 | $122.79 |
| Jul 31, 2026 | $121.44 |
| Aug 3, 2026 | $121.70 |
| Aug 4, 2026 | $122.72 |
| Aug 5, 2026 | $124.79 |
| Aug 6, 2026 | $124.17 |
| Aug 7, 2026 | $124.85 |
| Aug 10, 2026 | $125.45 |
| Aug 11, 2026 | $124.74 |
| Aug 12, 2026 | $125.00 |
| Aug 13, 2026 | $124.66 |
| Aug 14, 2026 | $125.36 |
| Aug 17, 2026 | $126.15 |
| Aug 18, 2026 | $127.89 |
| Aug 19, 2026 | $131.64 |
| Aug 20, 2026 | $128.89 |
| Aug 21, 2026 | $130.03 |
| Aug 24, 2026 | $130.03 |
| Aug 25, 2026 | $130.98 |
| Aug 26, 2026 | $130.06 |
| Aug 27, 2026 | $128.79 |
| Aug 28, 2026 | $127.26 |
| Aug 31, 2026 | $127.49 |
| Sep 1, 2026 | $128.02 |
| Sep 2, 2026 | $130.05 |
| Sep 3, 2026 | $129.59 |
| Sep 4, 2026 | $129.15 |
| Sep 8, 2026 | $126.58 |
| Sep 9, 2026 | $126.25 |
| Sep 10, 2026 | $124.74 |
| Sep 11, 2026 | $124.09 |
| Sep 14, 2026 | $124.96 |
| Sep 15, 2026 | $123.76 |
| Sep 16, 2026 | $124.70 |
| Sep 17, 2026 | $125.93 |
| Sep 18, 2026 | $125.26 |
| Sep 21, 2026 | $126.48 |
| Sep 22, 2026 | $127.37 |
| Sep 23, 2026 | $125.46 |
| Sep 24, 2026 | $126.48 |
| Sep 25, 2026 | $126.82 |
| Sep 28, 2026 | $127.11 |
| Sep 29, 2026 | $126.13 |
| Sep 30, 2026 | $123.31 |
| Oct 1, 2026 | $121.24 |
| Oct 2, 2026 | $120.88 |
| Oct 5, 2026 | $121.10 |
| Oct 6, 2026 | $120.71 |
| Oct 7, 2026 | $121.53 |
| Oct 8, 2026 | $120.99 |
| Oct 9, 2026 | $122.88 |
| Oct 12, 2026 | $123.44 |
| Oct 13, 2026 | $120.92 |
| Oct 14, 2026 | $123.40 |
| Oct 15, 2026 | $125.13 |
| Oct 16, 2026 | $124.46 |
| Oct 19, 2026 | $123.52 |
| Oct 20, 2026 | $126.41 |
| Oct 21, 2026 | $125.76 |
| Oct 22, 2026 | $127.31 |
| Oct 23, 2026 | $125.03 |
| Oct 26, 2026 | $125.80 |
| Oct 27, 2026 | $126.36 |
Weekly net flows, 3M
Net inflow over the range: +$96M
- Inflow / above zero
- Outflow / below zero
Source: Daily creation and redemption records
Show as table
| Label | Value ($) |
|---|---|
| Jul 27 | $25.5M |
| Aug 3 | $19.7M |
| Aug 10 | $6.3M |
| Aug 17 | $2.6M |
| Aug 24 | $5.2M |
| Aug 31 | $27.1M |
| Sep 7 | $2.5M |
| Sep 14 | −$1.2M |
| Sep 21 | $13.9M |
| Sep 28 | $1.4M |
| Oct 5 | −$4.8M |
| Oct 12 | −$2.5M |
| Oct 19 | $0 |
| Oct 26 | $0 |
The desk’s read
Money is leaving — −$6M in net outflows over the past month, about 1.1% of the fund's asset base, while the price has returned +20.9% so far this year. At 0.57% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
$558Massets under management
0.57%expense ratio · $57 per $10,000 a year
−$6Mnet flow, trailing month
37Kavg daily volume, 30 days
23holdings · US-domiciled
2005listed June 23, 2005 · beta 0.42
The book at a glance
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
Holdings
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | ABBVABBVIE | 5.98% | $286.39 | -0.1% | ||
| 2 | GILDGILEAD SCIENCES | 5.88% | $159.08 | +0.2% | ||
| 3 | PFEPFIZER | 5.75% | $29.80 | +0.0% | ||
| 4 | LLYELI LILLY | 5.72% | $1281.91 | +0.2% | ||
| 5 | AMGNAMGEN | 5.53% | $447.95 | +0.7% | ||
| 6 | JNJJOHNSON & JOHNSON | 5.38% | $268.73 | +0.9% | ||
| 7 | MRKMERCK & CO | 4.96% | $141.82 | +0.9% | ||
| 8 | ABTABBOTT LABORATORIES | 5.00% | $103.10 | -1.7% | ||
| 9 | AMRXAMNEAL PHARMACEUTICALS | 3.69% | $21.44 | +2.0% | ||
| 10 | BIIBBIOGEN | 3.59% | $252.73 | +0.2% | ||
| 11 | UTHRUNITED THERAPEUTICS | 3.59% | $591.20 | -0.3% | ||
| 12 | VTRSVIATRIS | 3.44% | $18.72 | +2.4% | ||
| 13 | LGNDLIGAND PHARMACEUTICALS | 3.44% | $311.73 | +1.1% | ||
| 14 | PRGOPERRIGO CO | 3.43% | $16.02 | +1.3% | ||
| 15 | TARSTARSUS PHARMACEUTICALS | 3.08% | $70.76 | +1.0% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 23Sector weights
- Healthcare100%
- Health Technology99.88%
- Other0.17%
- Mutual fund0.12%
Source: Portfolio composition, latest disclosure
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 100% |
| Health Technology | 99.88% |
| Other | 0.17% |
| Mutual fund | 0.12% |
Country weights
- United States100%
- Ireland6.52%
- Canada3.9%
- Israel3.59%
- Other0.09%
Source: Portfolio composition, latest disclosure
Show as table
| Item | Value (%) |
|---|---|
| United States | 100% |
| Ireland | 6.52% |
| Canada | 3.9% |
| Israel | 3.59% |
| Other | 0.09% |
Performance
| 1 week | +0.5% |
| 1 month | -0.4% |
| 3 months | +4.8% |
| 6 months | +21.5% |
| YTD | +20.9% |
| 1 year | +32.6% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
Net flows
| 1 week | — |
| 1 month | −$6M |
| 3 months | +$96M |
| YTD | +$193M |
| 1 year | +$193M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Source: Daily creation/redemption records, trailing twelve months
Show as table
| Label | Value ($) |
|---|---|
| Aug | −$910K |
| Sep | $10K |
| Oct | $0 |
| Feb | $109M |
| Mar | −$2M |
| Apr | −$69.1M |
| May | −$7.4M |
| Jun | −$11.4M |
| Jul | $103.8M |
| Aug | $36.3M |
| Sep | $43.5M |
| Oct | −$9.8M |
The risk read
21%realized volatility, 30 days (annualized)
17%realized volatility, 1 year
-9.7%deepest fall from a peak, 1 year
-4.0%latest close versus that peak
The top holding is 6.0% of the book; the top ten carry 51%. Spread across 29+ names, it behaves like roughly 24 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
Options tape
1calls · latest snapshot
1puts · latest snapshot
1.00put/call ratio
20Kshares traded
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| AMGN AMGEN | $64M | $2M |
| LLY ELI LILLY | $24M | $26M |
| MRK MERCK & CO | $3M | $4M |
| JNJ JOHNSON & JOHNSON | $4M | $3M |
| ABBV ABBVIE | $3M | $3M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES